{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:20:42Z","timestamp":1782926442082,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cjca.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:33:42Z","timestamp":1747251222000},"page":"1457-1465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Percutaneous Endocardial Septal Radiofrequency Ablation With Alcohol Septal Ablation in Treating Hypertrophic Obstructive Cardiomyopathy"],"prefix":"10.1016","volume":"41","author":[{"given":"Aiju","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-421X","authenticated-orcid":false,"given":"Chengzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","article-title":"Hypertrophic cardiomyopathy: clinical update","volume":"6","author":"Geske","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jacc.2024.11.030","article-title":"A more accurate diagnosis of hypertrophic cardiomyopathy: simplifying the complex through use of AI technologies","volume":"85","author":"McKenna","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib4","first-page":"1503","article-title":"Canadian Cardiovascular Society clinical practice update on contemporary management of the patient with hypertrophic cardiomyopathy","volume":"40","author":"Crean","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1093\/eurheartj\/ehae710","article-title":"Advances in the treatment of hypertrophic cardiomyopathy","volume":"45","author":"Braunwald","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.005_bib6","article-title":"Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"24","author":"Canzi","year":"2022","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.cjca.2025.05.005_bib7","first-page":"833","article-title":"Interventions in hypertrophic obstructive cardiomyopathy","volume":"40","author":"Ding","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.21037\/cdt.2020.01.12","article-title":"Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background","volume":"10","author":"Bonaventura","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.cjca.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pcad.2023.08.003","article-title":"Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy","volume":"80","author":"Mehra","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.33678\/cor.2021.124","article-title":"Efficacy and safety of endocardial radiofrequency catheter ablation of interventricular septal hypertrophy in the treatment of hypertrophic obstructive cardiomyopathy","volume":"64","author":"Dole\u017ealov\u00e1","year":"2022","journal-title":"Cor et Vasa"},{"key":"10.1016\/j.cjca.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/clc.23341","article-title":"Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis","volume":"43","author":"Yang","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1097\/MS9.0000000000002243","article-title":"Percutaneous endocardial septal radiofrequency ablation on syncope in patients with hypertrophic obstructive cardiomyopathy: a short-term safety and efficacy study","volume":"86","author":"Tian","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.cjca.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjcard.2014.11.030","article-title":"Biventricular reverse remodeling after successful alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"115","author":"Chen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2003.03.005","article-title":"Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: the Chinese experience in 119 patients from a single center","volume":"93","author":"Li","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jjcc.2014.08.010","article-title":"Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy","volume":"66","author":"Sedehi","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.21037\/atm-21-2783","article-title":"A modified endocardial radiofrequency ablation approach for hypertrophic obstructive cardiomyopathy guided by transthoracic echocardiography: a case series","volume":"9","author":"Kong","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cjca.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","article-title":"Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients","volume":"57","author":"Lawrenz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/europace\/euv302","article-title":"Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of Cartosound\u00ae technology to guide ablation","volume":"18","author":"Cooper","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.005_bib20","first-page":"120","article-title":"Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy","volume":"114","author":"Yuan","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.cjca.2025.05.005_bib21","series-title":"Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study","first-page":"101","volume":"84","author":"Veselka","year":"2014"},{"key":"10.1016\/j.cjca.2025.05.005_bib22","first-page":"3549","article-title":"Efficacy and safety of radiofrequency catheter ablation of septal hypertrophy guided by intracardiac echocardiography in hypertrophic obstructive cardiomyopathy [in Chinese]","volume":"102","author":"Guo","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.cjca.2025.05.005_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtcvs.2018.08.062","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort","volume":"157","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25003381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25003381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:27:42Z","timestamp":1758133662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25003381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0828282X25003381"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.005","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Percutaneous Endocardial Septal Radiofrequency Ablation With Alcohol Septal Ablation in Treating Hypertrophic Obstructive Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}